Neurent Medical
PrivateLast Round
Series C
Feb 11, 2026
Total Funding Raised
$129.47M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neurent Medical is a medical device company that develops minimally invasive, non-surgical treatments for chronic inflammatory sinonasal diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurent Medical Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Neurent Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 11, 2026 | ||||
| Debt | Dec 18, 2024 | ||||
| Series B | Jan 20, 2021 | ||||
| Grant | Jul 9, 2020 | ||||
| Series A | May 28, 2018 |
Key People
Founding team and executive leadership
Neurent Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Atlantic Bridge Capital | Series C, Series B, Series A |
| EQT Life Sciences | Series C, Series B |
| Claret Capital Partners | Debt |
| Western Development Commission | Series A |
| Fountain Healthcare Partners | Series C, Series B, Series A |
| EIT Health | Grant |
| Sofinnova Partners | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 11, 2026
$74M round led by MVM Life Science Partners.
- Dec 18, 2024
$19M round led by Claret Capital Partners
Neurent Medical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neurent Medical's valuation, stock price, and market status.